MLchartDataset catalogue

Elacyt

Term · Oncology and biomedicine · MLC-T-ONC-002714

A drug used to treat advanced acute myeloid leukemia (AML). It is a form of the anticancer drug cytarabine that may work in patients with leukemia that is resistant to cytarabine. Elacyt blocks cell division and may kill cancer cells. It is a type of antimetabolite. Also called CP-4055 and elacytarabine.

Table 1. Record
IdentifierMLC-T-ONC-002714
FieldOncology and biomedicine
SynonymsCP-4055; elacytarabine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002714",
  "term": "Elacyt",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat advanced acute myeloid leukemia (AML). It is a form of the anticancer drug cytarabine that may work in patients with leukemia that is resistant to cytarabine. Elacyt blocks cell division and may kill cancer cells. It is a type of antimetabolite. Also called CP-4055 and elacytarabine.",
  "synonyms": [
    "CP-4055",
    "elacytarabine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/elacyt/"
}

Record 6,498 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.